Healthcare >> CEO Interviews >> May 7, 2001

Mark Mcdade – Signature Bioscience Inc

MARK MCDADE, CEO of Signature BioScience, Inc., joined the company from his position as President and Chief Operating Officer of Corixa Corporation. At Corixa, he served as Executive Vice President and Chief Operating Officer since the company's inception, and as President and COO since March 1999; he will remain on the Board of Directors, while resigning his executive position by year-end. Prior to co-founding Corixa, Mr. McDade served as the Chief Operating Officer of Boehringer Mannheim Therapeutics, the pharmaceutical division of Corange Ltd. His prior experience includes various management positions with Sandoz Ltd. Mr. McDade also serves on the Board of Directors of Valentis, Inc., of Burlingame, CA. Mr. McDade graduated from Dartmouth College and received his MBA from Harvard University. Profile
TWST: Can we start out with a history and a quick overview of Signature

BioScience?

Mr. McDade: Signature was formed in late 1998 by founder and Chief

Technology Officer, John Hefti. On the